CERo Therapeutics (CERO) announces that the U.S. Food and Drug Administration has cleared the Company’s Investigational New Drug ...

Daré will host a conference call and live webcast today, November 14, 2024, at 4:30 p.m. Eastern Time to review financial ...

With submission of the updated Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) this week, the Company expects the FDA clearance decision by mid-December, ...

Submission of New Drug Application for Paltusotine for the Treatment of AcromegalyCompleted Upsized Public Offering of $575M of Common Stock ...

Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and ...

Multiple myeloma is the second most common hematologic malignancy, but there is a treatment gap for patients with disease ...

WELL, IT’S FREE. ANONYMOUS. NO QUESTIONS ASKED. AND IF IT COULD MAKE A BIG DIFFERENCE IN KEEPING POTENTIALLY HARMFUL DRUGS OUT OF THE HANDS OF PEOPLE WHO DO NOT NEED THEM. TODAY, FROM 10 A.M. TO ...

2:19 Animal activists launch a lawsuit against the province for not shutting down a coyote hunting contest Ontario has recently made the decision to open up new applications for train and trial ...

We expect to submit an investigational new drug application (IND) and non-U.S. applications for ZW220 in the first half of 2025. ZW251, a potential first-in-class ADC molecule designed for the ...

Now, researchers have identified two new potential drugs that reduced parasite numbers in infected calves and immunocompromised mice. The results were published in Science Translational Medicine ...

Its far easier to get a new nicotine pouch (such as Zyn) through the FDA’s Center for Tobacco Products than it is to get a cessation therapy through the regulator’s Center for Drug Evaluation ...

We expect to submit an investigational new drug application (IND) and non-U.S. applications for ZW220 in the first half of 2025. Zymeworks is a global clinical-stage biotechnology company committed to ...